里格尔制药 RIGL
$39.65 −$6.06 (-13.26%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $39.65 0.00%
开盘$41.11
昨收$45.71
当日区间$37.60 – $41.67
成交量759.2K
市值$746.61M
市盈率（TTM）2.5
股息率–
财报
财报日平均波动±11.6%近16次财报
收涨次数11 / 1669% 的概率
最佳反应+42.9%
最差反应-16.6%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 4 Aug 2026 | After Market | ±15.1% | +4.60% | 符合区间 |
| 2026/Q1 | 5 May 2026 | After Market | ±17.7% | -5.06% | 符合区间 |
| 2025/Q4 | 3 Mar 2026 | After Market | ±19.7% | -10.27% | 符合区间 |
| 2025/Q3 | 4 Nov 2025 | After Market | ±16.5% | +33.37% | 超出定价预期 |
| 2025/Q2 | 5 Aug 2025 | After Market | ±14.2% | +22.98% | 超出定价预期 |
| 2025/Q1 | 6 May 2025 | After Market | ±9.8% | +1.15% | 符合区间 |
| 2024/Q4 | 4 Mar 2025 | After Market | ±15.7% | -8.11% | 符合区间 |
| 2024/Q3 | 7 Nov 2024 | After Market | ±22.7% | +42.94% | 超出定价预期 |
| 2024/Q2 | 6 Aug 2024 | After Market | ±19.3% | +5.79% | 符合区间 |
| 2024/Q1 | 7 May 2024 | After Market | ±25.2% | -16.61% | 符合区间 |
| 2023/Q4 | 5 Mar 2024 | After Market | ±25.4% | +5.41% | 符合区间 |
| 2023/Q3 | 7 Nov 2023 | After Market | ±28.7% | +2.24% | 符合区间 |
| 2023/Q2 | 1 Aug 2023 | After Market | ±36.1% | -3.01% | 符合区间 |
| 2023/Q1 | 2 May 2023 | After Market | ±26.3% | +0.88% | 符合区间 |
| 2022/Q4 | 7 Mar 2023 | After Market | ±40.1% | +21.77% | 符合区间 |
| 2022/Q3 | 3 Nov 2022 | After Market | ±41.4% | +2.00% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q2, ended Jun 2026
营收$78.70M-22.6% YoY
营业利润$23.58M-61.4% YoY
净利润$17.29M-71.0% YoY
摊薄每股收益$0.88-73.2% YoY
自由现金流-$39.69M-230.0% YoY
经营现金流$30.65M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率91.4%
营业利润率31.5%
净利率116.3%
净资产收益率126.9%
资产收益率88.5%
投入资本回报率106.1%
流动比率1.94
负债/资产比率18.4%
现金及投资$95.33M
总负债$39.29M
净现金（净负债）$56.04M
自由现金流/营收3.3%
暂无评论——快来第一个聊聊 RIGL。
登录后参与讨论。